KDT-3594 ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
6Parkinson disease3

6. Parkinson disease


Clinical trials : 2,298 Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04867551
(ClinicalTrials.gov)
May 15, 202127/4/2021A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's DiseaseA Phase II Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's DiseaseParkinson DiseaseDrug: KDT-3594Kissei Pharmaceutical Co., Ltd.NULLActive, not recruiting20 Years79 YearsAll6Phase 2Japan
2NCT03845387
(ClinicalTrials.gov)
February 26, 201915/2/2019A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.A Phase II Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.Parkinson DiseaseDrug: KDT-3594;Drug: PramipexoleKissei Pharmaceutical Co., Ltd.NULLCompleted20 Years79 YearsAll74Phase 2Japan
3NCT03068481
(ClinicalTrials.gov)
February 20, 201726/2/2017Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's DiseaseA Phase I Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's DiseaseParkinson DiseaseDrug: KDT-3594;Drug: PlaceboKissei Pharmaceutical Co., Ltd.NULLCompleted20 Years74 YearsAll36Phase 1Japan